We are live on
!
Find out more
EVOK
Evoke Pharma
EVOK
EVOK
Delisted
EVOK was delisted on the 16th of December, 2025.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
OM
1
Opaleye Management
Boston,
Massachusetts
| $1.96M | +$72.4K | +63 | +4% |
|
| 2 |
SC
2
Sophrosyne Capital
New York
| $397K | – | – | – |
|
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
| $378K | +$8.04K | +7 | +2% |
|
| 4 |
4
Bank of America
Charlotte,
North Carolina
| $271K | – | – | – |
|
| 5 |
LP
5
LMR Partners
London,
United Kingdom
| $187K | – | – | – |
|
| 6 |
6
Geode Capital Management
Boston,
Massachusetts
| $80K | – | – | – |
|
| 7 |
U
7
UBS
Zurich,
Switzerland
| $6K | -$4.59K | -4 | -44% |
|
| 8 |
8
Morgan Stanley
New York
| $4K | – | – | – |
|
| 9 |
BIM
9
BlackRock Investment Management
Wilmington,
Delaware
| $4K | +$3.45K | +3 | New |
|
| 10 |
TRCT
10
Tower Research Capital (TRC)
New York
| $1K | +$1.15K | +1 | New |
|
| 11 |
TC
11
TFS Capital
West Chester,
Pennsylvania
| – | -$88K | -73 | Closed |
|
| 12 |
12
Citigroup
New York
| – | -$17K | -14 | Closed |
|